S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 61 to 120 of 164

Issue Date	Title / Author(s) / Citation	File
2016-07	Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX Kim, Mi-Jung; Han, Sae-Won; Lee, Dae-Won; Cha, Yongjun; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Kim, Se Hyung; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Cancer Research and Treatment, Vol.48 No.3, pp.990-997	DOI
2016-07	Concurrent chemoradiotherapy versus chemotherapy alone for unresectable locally advanced pancreatic cancer: A retrospective cohort study Choi, Younak; Oh, Do-Youn; Kim, Kyubo; Chie, Eui Kyu; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Ha, Sung Whan; Bang, Yung-Jue Cancer Research and Treatment, Vol.48 No.3, pp.1045-1055	DOI
2016-07	Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses Yang, Yaewon; Im, Seock-Ah; Keam, Bhumsuk; Lee, Kyung-Hun; Kim, Tae-Yong; Suh, Koung Jin; Ryu, Han Suk; Moon, Hyeong-Gon; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Kim, Tae-You; Park, In Ae; Noh, Dong-Young BMC Cancer, Vol.16, p. 515	DOI
2016-07	Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer Suh, Koung Jin; Ryu, Han Suk; Lee, Kyung-Hun; Kim, Hyojin; Min, Ahrum; Kim, Tae-Yong; Yang, Yaewon; Moon, Hyeong-Gon; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Im, Seock-Ah Breast Cancer Research and Treatment, Vol.158 No.2, pp.233-241	DOI
2016-07	Early prediction of response to neoadjuvant chemotherapy in breast cancer patients: comparison of single-voxel H-1-magnetic resonance spectroscopy and F-18-fluorodeoxyglucose positron emission tomography Cho, Nariya; Im, Seock-Ah; Kang, Keon Wook; Park, In-Ae; Song, In Chan; Lee, Kyung-Hun; Kim, Tae-Yong; Lee, Hyunjong; Chun, In Kook; Yoon, Hai-Jeon; Moon, Woo Kyung European Radiology, Vol.26 No.7, pp.2279-2290	DOI
2016-07	Src as a Therapeutic Target in Biliary Tract Cancer Nam, Ah-Rong; Kim, Ji-Won; Park, Ji Eun; Bang, Ju-Hee; Jin, Mei Hua; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.15 No.7, pp.1515-1524	DOI
2016-07	Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database Shin, Sangjin; Park, Chan Mi; Kwon, Hanbyeol; Lee, Kyung-Hun BMC Cancer, 16(1):443	view file DOI
2016-08	Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancer Jin, Min-Sun; Lee, Hyebin; Park, In Ae; Chung, Yul Ri; Im, Seock-Ah; Lee, Kyung-Hun; Moon, Hyeong-Gon; Han, Wonshik; Kim, Kyubo; Kim, Tae-Yong; Noh, Dong-Young; Ryu, Han Suk Virchows Archiv, Vol.469 No.2, pp.183-190	DOI
2016-08	New insight on the biological role of p53 protein as a tumor suppressor: re-evaluation of its clinical significance in triple-negative breast cancer Jin, Min-Sun; Park, In Ae; Kim, Ji Young; Chung, Yul Ri; Im, Seock-Ah; Lee, Kyung-Hun; Moon, Hyeong-Gon; Han, Wonshik; Noh, Dong-Young; Ryu, Han Suk Tumor Biology, Vol.37 No.8, pp.11017-11024	DOI
2016-09	Therapeutic implication of HER2 in advanced biliary tract cancer Nam, Ah-Rong; Kim, Ji-Won; Cha, Yongjun; Ha, Hyerim; Park, Ji Eun; Bang, Ju-Hee; Jin, Mei Hua; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Oncotarget, Vol.7 No.36, pp.58007-58021	DOI
2016-10	Longitudinal Association of Poor Sleep Quality With Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer Jung, Dooyoung; Lee, Kwang-Min; Kim, Won-Hyoung; Lee, Joo-Young; Kim, Tae-Yong; Im, Seock-Ah; Lee, Kyung-Hun; Spiegel, David; Hahm, Bong-Jin Psychosomatic Medicine, Vol.78 No.8, pp.959-965	DOI
2016-11	Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy Ha, Hyerim; Nam, Ah-Rong; Bang, Ju-Hee; Park, Ji-Eun; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Oncotarget, Vol.7 No.47, pp.76604-76612	DOI
2016-11	TTP as a surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: meta-analysis of randomised controlled trials Lee, Dae-Won; Jang, Myoung-Jin; Lee, Kyung-Hun; Cho, Eun Ju; Lee, Jeong-Hoon; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You British Journal of Cancer, Vol.115 No.10, pp.1201-1205	DOI
2017-01	Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer Ock, Chan-Young; Nam, Ah-Rong; Bang, Ju-Hee; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Gastric Cancer, Vol.20 No.1, pp.164-174	DOI
2017-01	Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer Cho, Kyoung-Min; Park, Hyunkyung; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Oncotarget, Vol.8 No.2, pp.2329-2341	DOI
2017-03	Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer Ock, Chan-Young; Nam, Ah-Rong; Lee, Joongyub; Bang, Ju-Hee; Lee, Kyung-Hun; Han, Sae-Won; Kim, Tae-Yong; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Gastric Cancer, Vol.20 No.2, pp.254-262	DOI
2017-03	Optimal Timing of Influenza Vaccination During 3-Week Cytotoxic Chemotherapy Cycles Keam, Bhumsuk; Kim, Min-Kyung; Choi, Yunhee; Choi, Su-Jin; Choe, Pyoeng Gyun; Lee, Kyung-Hun; Kim, Tae Min; Kim, Tae-Yong; Oh, Do-Youn; Kim, Dong-Wan; Im, Seock-Ah; Kim, Nam-Joong; Heo, Dae Seog; Park, Wan Beom; Oh, Myoung-don Cancer, Vol.123 No.5, pp.841-848	DOI
2017-04	Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer in Korea Beom, Seung Hoon; Oh, Jisu; Kim, Tae-Yong; Lee, Kyung-Hun; Yang, Yaewon; Suh, Koung Jin; Moon, Hyeong-Gon; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Kim, Tae-You; Noh, Dong-Young; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.2, pp.454-463	DOI
2017-04	AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells Min, Ahrum; Im, Seock-Ah; Jang, Hyemin; Kim, Seongyeong; Lee, Miso; Kim, Debora Keunyoung; Yang, Yaewon; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Jin Won; Kim, Tae-Yong; Oh, Do-Youn; Brown, Jeff; Lau, Alan; O'Connor, Mark J.; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.16 No.4, pp.566-577	DOI
2017-05	Late chronotypes are associated with neoadjuvant chemotherapy-induced nausea and vomiting in women with breast cancer Lee, Kwang-Min; Jung, Doo-Young; Hwang, Heesung; Kim, Won-Hyoung; Lee, Joo-Young; Kim, Tae-Yong; Im, Seock-Ah; Lee, Kyung-Hun; Spiegel, David; Hahm, Bong-Jin Chronobiology International, Vol.34 No.4, pp.480-491	DOI
2017-07	Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis Kim, Seongyeong; Min, Ahrum; Lee, Kyung-Hun; Yang, Yaewon; Kim, Tae-Yong; Lim, Jee Min; Park, So Jung; Nam, Hyun-Jin; Kim, Jung Eun; Song, Sang-Hyun; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Kim, Tae-You; Hangauer, David; Lau, Johnson Yiu-Nam; Im, Kyongok; Lee, Dong Soon; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.3, pp.643-655	DOI
2017-07	CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy Lee, Dae-Won; Im, Seock-Ah; Kim, Yu Jung; Yang, Yaewon; Rhee, Jiyoung; Na, Im Ii; Lee, Kyung-Hun; Kim, Tae -Yong; Han, Sae -Won; Choi, In Sil; Oh, Do-Youn; Kim, Jee Hyun; Kim, Tae -You; Bang, Yung-Jue Cancer Research and Treatment, Vol.49 No.3, pp.807-815	DOI
2017-10	Korean Cancer Patients' Awareness of Clinical Trials, Perceptions on the Benefit and Willingness to Participate Lim, Yoojoo; Lim, Jee Min; Jeong, Won Jae; Lee, Kyung-Hun; Keam, Bhumsuk; Kim, Tae-Yong; Kim, Tae Min; Han, Sae-Won; Oh, Do Youn; Kim, Dong-Wan; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.4, pp.1033-1043	view file DOI
2017-10	Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors Suh, Koung Jin; Kim, Se Hyun; Lee, Kyung-Hun; Kim, Tae-Yong; Kim, Yu Jung; Han, Sae-Won; Kang, Eunyoung; Kim, Eun-Kyu; Kim, Kidong; No, Jae Hong; Han, Wonshik; Noh, Dong-Young; Lee, Maria; Kim, Hee Seung; Im, Seock-Ah; Kim, Jee Hyun Cancer Research and Treatment, Vol.49 No.4, pp.1153-1163	DOI
2017-11	Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer Park, Yeon Hee; Im, Seock-Ah; Kim, Sung-Bae; Sohn, Joo Hyuk; Lee, Keun Seok; Chae, Yee Soo; Lee, Ki Hyeong; Kim, Jee Hyun; Im, Young-Hyuck; Kim, Ji-Yeon; Kim, Tae-Yong; Lee, Kyung-Hun; Ahn, Jin-Hee; Kim, Gun Min; Park, In Hae; Lee, Soo Jung; Han, Hye Sook; Kim, Se Hyun; Jung, Kyung Hae; Korean Cancer Study Group (KCSG) European Journal of Cancer, Vol.86, pp.385-393	DOI
2017-12	Cyclophosphamide, Methotrexate, and 5-Fluorouracil as Palliative Treatment for Heavily Pretreated Patients with Metastatic Breast Cancer: A Multicenter Retrospective Analysis Park, Jin Hyun; Im, Seock-Ah; Byun, Ja Min; Kim, Ki Hwan; Kim, Jin-Soo; Choi, In Sil; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do Youn; Kim, Tae-You Journal of Breast Cancer, Vol.20 No.4, pp.347-355	DOI
2017-12	Treatment Patterns and Outcomes in Elderly Patients with Metastatic Breast Cancer: A Multicenter Retrospective Study Park, Jin Hyun; Choi, In Sil; Kim, Ki Hwan; Kim, Jin-Soo; Lee, Kyung-Hun; Kim, Tae-Yong; Im, Seock Ah; Kim, Se Hyun; Kim, Yu Jung; Kim, Jee Hyun Journal of Breast Cancer, Vol.20 No.4, pp.368-377	DOI
2018-01	S-1-induced lacrimal drainage obstruction and its association with ingredients/metabolites of S-1 in tears and plasma: A prospective multi-institutional study Kim, Namju; Kim, Jin Won; Baek, Je-Hyun; Kim, Jin-Soo; Choung, Ho-Kyung; Kim, Tae-Yong; Lee, Kyung-Hun; Bang, Yung-Jue; Khwarg, Sang In; Ahn, Sang-Hoon; Park, Do Joong; Kim, Hyung-Ho; Chung, Jae-Yong; Ahn, Soyeon; Lee, Keun-Wook Cancer Research and Treatment, Vol.50 No.1, pp.30-39	DOI
2018-03	Integrated 18F-FDG PET/MRI in breast cancer: Early prediction of response to neoadjuvant chemotherapy Cho, Nariya; Im, Seock-Ah; Cheon, Gi Jeong; Park, In-Ae; Lee, Kyung-Hun; Kim, Tae-Yong; Kim, Young Seon; Kwon, Bo Ra; Lee, Jung Min; Suh, Hoon Young; Suh, Koung Jin European Journal of Nuclear Medicine and Molecular Imaging, Vol.45 No.3, pp.328-339	DOI
2018-03	A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma Lee, Dae-Won; Lee, Kyung-Hun; Kim, Hee-Jun; Kim, Tae-Yong; Kim, Jin-Soo; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Im, Seock-Ah; Kim, Tae-You BMC Cancer, Vol.18 No.1, p. 252	DOI
2018-05	Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells Min, Ahrum; Kim, Jung Eun; Kim, Yu-Jin; Lim, Jee Min; Kim, Seongyeong; Kim, Jin Won; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Bang, Yung-Jue; Im, Seock-Ah Cancer Letters, Vol.430, pp.123-132	DOI
2018-05	Pre-treatment anxiety is associated with persistent chemotherapy-induced peripheral neuropathy in women treated with neoadjuvant chemotherapy for breast cancer Lee, Kwang-Min; Jung, Dooyoung; Hwang, Heesung; Son, Kyung-Lak; Kim, Tae-Yong; Im, Seock-Ah; Lee, Kyung-Hun; Hahm, Bong-Jin Journal of Psychosomatic Research, Vol.108, pp.14-19	DOI
2018-11	Fulvestrant plus goserelin versus anastrozole plus goserelin versus goserelin alone for hormone receptor-positive, HER2-negative tamoxifen-pretreated premenopausal women with recurrent or metastatic breast cancer (KCSG BR10-04): a multicentre, open-label, three-arm, randomised phase II trial (FLAG study) Kim, Ji-Yeon; Im, Seock-Ah; Jung, Kyung Hae; Ro, Jungsil; Sohn, Joohyuk; Kim, Jee Hyun; Park, Yeon Hee; Kim, Tae-Yong; Kim, Sung-Bae; Lee, Keun Seok; Kim, Gun Min; Kim, Se Hyun; Kim, Seonwoo; Ahn, Jin Seok; Lee, Kyung-Hun; Ahn, Jin-Hee; Park, In Hae; Im, Young-Hyuck European Journal of Cancer, Vol.103, pp.127-136	DOI
2018-12	A phase II trial of the pan-HER inhibitor poziotinib, in patients with HER2-positive metastatic breast cancer who had received at least two prior HER2-directed regimens: results of the NOV120101-203 trial Park, Yeon Hee; Lee, Kyung-Hun; Sohn, Joo Hyuk; Lee, Keun Seok; Jung, Kyung Hae; Kim, Jee-Hyun; Lee, Ki Hyeong; Ahn, Jin Seok; Kim, Tae-Yong; Kim, Gun Min; Park, In Hae; Kim, Sung-Bae; Kim, Se Hyun; Han, Hye Sook; Im, Young-Hyuck; Ahn, Jin-Hee; Kim, Jung-Yong; Kang, Jahoon; Im, Seock-Ah International Journal of Cancer, Vol.143 No.12, pp.3240-3247	DOI
2018-12	Effects of trastuzumab on locoregional recurrence in human epidermal growth factor receptor 2-overexpressing breast cancer patients treated with chemotherapy and radiotherapy Jeon, Seung Hyuck; Shin, Kyung Hwan; Kim, Jin Ho; Kim, Kyubo; Kim, In Ah; Lee, Kyung-Hun; Kim, Tae-Yong; Im, Seock-Ah Breast Cancer Research and Treatment, Vol.172 No.3, pp.619-626	DOI
2018-12	Androgen receptor inhibitor enhances the antitumor effect of PARP inhibitor in breast cancer cells by modulating DNA damage response Min, Ahrum; Jang, Hyemin; Kim, Seongyeong; Lee, Kyung-Hun; Kim, Debora Keunyoung; Suh, Koung Jin; Yang, Yaewon; Elvin, Paul; O'Connor, Mark J.; Im, Seock-Ah Molecular Cancer Therapeutics, Vol.17 No.12, pp.2507-2518	DOI
2019-01	Randomized Open Labe Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01) Park, In Hae; Im, Seock-Ah; Jung, Kyung Hae; Sohn, Joo Hyuk; Park, Yeon Hee; Lee, Keun Seok; Sim, Sung Hoon; Park, Kyong-Hwa; Kim, Jee Hyun; Nam, Byung Ho; Kim, Hee-Jun; Kim, Tae-Yong; Lee, Kyung-Hun; Kim, Sung-Bae; Ahn, Jin-Hee; Lee, Suee; Ro, Jungsil Cancer Research and Treatment, Vol.51 No.1, pp.43-52	DOI
2019-04	Pan-PIM kinase inhibitor AZD1208 suppresses tumor growth and synergistically interacts with AKT inhibition in gastric cancer cells Lee, Miso; Lee, Kyung-Hun; Min, Ahrum; Kim, Jeongeun; Kim, Seongyeong; Jang, Hyemin; Lim, Jee Min; Kim, So Hyeon; Ha, Dong-Hyeon; Jeong, Won Jae; Suh, Koung Jin; Yang, Yae-Won; Kim, Tae Yong; Oh, Do-Youn; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.51 No.2, pp.451-463	DOI
2019-05	Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11) Kim, Ji-Yeon; Park, Seri; Im, Seock-Ah; Kim, Sung-Bae; Sohn, Joohyuk; Lee, Keun Seok; Chae, Yee Soo; Lee, Ki Hyeong; Kim, Jee Hyun; Im, Young-Hyuck; Kim, Tae-Yong; Lee, Kyung-Hun; Ahn, Jin-Hee; Kim, Gun Min; Park, In Hae; Lee, Soo Jung; Han, Hye Sook; Kim, Se Hyun; Jung, Kyung Hae; Park, Yeon Hee Cancer Communications, Vol.39 No.1, pp.1-8	view file DOI
2019-05	Prognostic effects of abnormal DNA damage response protein expression in breast cancer Suh, Koung Jin; Ryu, Han Suk; Lee, Kyung-Hun; Kim, Hyojin; Min, Ahrum; Kim, Tae-Yong; Yang, Yaewon; Lee, Han-Byoel; Moon, Hyeong-Gon; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Im, Seock-Ah Breast Cancer Research and Treatment, Vol.175 No.1, pp.117-127	DOI
2019-07	Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients Kim, Jung Youn; Lee, Dae-Won; Lee, Kyung-Hun; Min, Ahrum; Ryu, Han Suk; Lee, Han-Byoel; Moon, Hyeong-Gon; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Im, Seock-Ah; Kim, Sukil Breast Cancer Research and Treatment, Vol.176 No.2, pp.453-460	DOI
2019-07	Immune recurrence score using 7 immunoregulatory protein expressions can predict recurrence in stage I–III breast cancer patients Lee, Dae-Won; Ryu, Han Suk; Jin, Min-Sun; Lee, Kyung-Hun; Suh, Koung Jin; Youk, Jeonghwan; Kim, Jung Youn; Min, Ahrum; Lee, Han-Byoel; Moon, Hyeong-Gon; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Im, Seock-Ah British Journal of Cancer, Vol.121 No.3, pp.230-236	DOI
2019-08	Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: Phase Ib study Kim, Jin Won; Lee, Kyung-Hun; Kim, Ji-Won; Suh, Koung Jin; Nam, Ah-Rong; Bang, Ju-Hee; Bang, Yung-Jue; Oh, Do-Youn British Journal of Cancer, Vol.121 No.4, pp.332-339	DOI
2019-09	Molecular alterations and poziotinib efficacy, a pan-HER inhibitor, in human epidermal growth factor receptor 2 (HER2)-positive breast cancers: Combined exploratory biomarker analysis from a phase II clinical trial of poziotinib for refractory HER2-positive breast cancer patients Kim, Ji-Yeon; Lee, Eunjin; Park, Kyunghee; Jung, Hae Hyun; Park, Woong-Yang; Lee, Kyung-Hun; Sohn, Joohyuk; Lee, Keun Seok; Jung, Kyung Hae; Kim, Jee Hyun; Lee, Ki Hyeong; Im, Seock-Ah; Park, Yeon Hee International Journal of Cancer, Vol.145 No.6, pp.1669-1678	DOI
2019-10	Treating HR+/HER2-breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression Yeo, Winnie; Ueno, Takayuki; Lin, Ching-Hung; Liu, Qiang; Lee, Kyung-Hun; Leung, Roland; Naito, Yoichi; Park, Yeon Hee; Im, Seock-Ah; Li, Huiping; Yap, Yoon Sim; Lu, Yen-Shen Breast Cancer Research and Treatment, Vol.177 No.3, pp.549-559	DOI
2019-11	A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer Kim, Tae-Yong; Han, Hye Sook; Lee, Keun-Wook; Zang, Dae Young; Rha, Sun Young; Park, Young lee; Kim, Jin-Soo; Lee, Kyung-Hun; Park, Se Hoon; Song, Eun-Kee; Jung, Soo-A; Lee, NaMi; Kim, Yeul Hong; Cho, Jae Yong; Bang, Yung-Jue Gastric Cancer, Vol.22 No.6, pp.1206-1214	DOI
2019-12	Prognostic Impact of Pregnancy in Korean Patients with Breast Cancer Choi, Mihong; Han, Jiyeon; Yang, Bo Ram; Jang, Myoung-jin; Kim, Miso; Kim, Tae-Yong; Im, Seock-Ah; Lee, Han-Byoel; Moon, Hyeong-Gon; Han, Wonshik; Noh, Dong-Young; Lee, Kyung-Hun Oncologist, Vol.24 No.12, pp.e1268-e1276	DOI
2019-12	Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2+metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16) Sim, Sung Hoon; Park, In Hae; Jung, Kyung Hae; Kim, Sung-Bae; Ahn, Jin-Hee; Lee, Kyung-Hun; Im, Seock-Ah; Im, Young-Hyuck; Park, Yeon Hee; Sohn, Joohyuk; Kim, Yu Jung; Lee, Suee; Kim, Hee-Jun; Chae, Yee Soo; Park, Kyong Hwa; Nam, Byung-Ho; Lee, Keun Seok; Ro, Jungsil British Journal of Cancer, Vol.121 No.12, pp.985-990	DOI
2019-12	Amenorrhea and menopause in patients with breast cancer after chemotherapy Shin, Jae Jun; Choi, Young Min; Jun, Jong Kwan; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Wonshik; Im, Seock-Ah Journal of Breast Cancer, Vol.22 No.4, pp.624-634	DOI
2019-12	Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): A multicentre, open-label, randomised, phase 2 trial Park, Yeon Hee; Kim, Tae-Yong; Kim, Gun Min; Kang, Seok Yun; Park, In Hae; Kim, Jee Hyun; Lee, Kyoung Eun; Ahn, Hee Kyung; Lee, Moon Hee; Kim, Hee-Jun; Kim, Han Jo; Lee, Jong In; Koh, Su-Jin; Kim, Ji-Yeon; Lee, Kyung-Hun; Sohn, Joohyuk; Kim, Sung-Bae; Ahn, Jin-Seok; Im, Young-Hyuck; Jung, Kyung Hae; Im, Seock-Ah The Lancet Oncology, Vol.20 No.12, pp.1750-1759	DOI
2019-12	Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population Lin, Ching-Hung; Yap, Yoon Sim; Lee, Kyung-Hun; Im, Seock-Ah; Naito, Yoichi; Yeo, Winnie; Ueno, Takayuki; Kwong, Ava; Li, Huiping; Huang, Shu-Min; Leung, Roland; Han, Wonshik; Tan, Benita; Hu, Fu-Chang; Huang, Chiun-Sheng; Cheng, Ann-Lii; Lu, Yen-Shen; Asian Breast Cancer Cooperative Group; Noh, Dong Young Journal of the National Cancer Institute, Vol.111 No.12, pp.1298-1306	DOI
2019-12	Targeted next-generation DNA sequencing identifies Notch signaling pathway mutation as a predictor of radiation response Jeon, Seung Hyuck; Chie, Eui Kyu; Kim, Yi-Jun; Lee, Kyung-Hun; Lee, Hyun-Seob; Kim, Min Jung; Im, Seock-Ah; Kim, Jong-Il; Kim, Tae-You International Journal of Radiation Biology, Vol.95 No.12, pp.1640-1647	DOI
2020-02	TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy Kim, Jin Won; Min, Ahrum; Im, Seock-Ah; Jang, Hyemin; Kim, Yu Jin; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Tae-Yong; Lee, Keun Wook; Oh, Do-Youn; Kim, Jee-Hyun; Bang, Yung-Jue Cancers, Vol.12 No.2, p. 334	view file DOI
2020-02	Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study Bang, Yung-Jue; Li, Chung-Pin; Lee, Kyung-Hun; Chiu, Chang-Fang; Park, Joon Oh; Shan, Yan-Shen; Kim, Jun Suk; Chen, Jen-Shi; Shim, Hyun-Jeong; Rau, Kun-Ming; Choi, Hye Jin; Oh, Do-Youn; Belanger, Bruce; Chen, Li-Tzong Cancer Science, Vol.111 No.2, pp.513-527	view file DOI
2020-03	Morning chronotype is a protective factor against chemotherapy-induced hot flashes in premenopausal women with breast cancer Son, Kyung-Lak; Jung, Dooyoung; Lee, Kwang-Min; Hwang, Heesung; Lee, JooYoung; Kim, Tae-Yong; Im, Seock-Ah; Lee, Kyung-Hun; Spiegel, David; Hahm, Bong-Jin Supportive Care in Cancer, Vol.28 No.3, pp.1351-1358	DOI
2020-03	The effect of perceived social support on chemotherapy-related symptoms in patients with breast cancer: A prospective observational study Oh, Gyu Han; Yeom, Chan-Woo; Shim, Eun-Jung; Jung, Dooyoung; Lee, Kwang-Min; Son, Kyung-Lak; Kim, Won-Hyoung; Moon, Jung Yoon; Jung, Sanghyup; Kim, Tae-Yong; Im, Seock-Ah; Lee, Kyung-Hun; Hahm, Bong-Jin Journal of Psychosomatic Research, Vol.130, p. 109911	DOI
2020-04	Prognostic role of androgen receptor expression in surgically resected early breast cancer patients Yang, Yaewon; Min, Ahrum; Lee, Kyung-Hun; Ryu, Han Suk; Kim, Tae-Yong; Woo, Go-un; Suh, Koung Jin; Lee, Dae-Won; Lee, Han-Byoel; Moon, Hyeong-Gon; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Im, Seock-Ah Journal of Breast Cancer, Vol.23 No.2, pp.182-193	DOI
2020-04	Development of a Nomogram to Predict the Recurrence Score of 21-Gene Prediction Assay in Hormone Receptor–Positive Early Breast Cancer Yoo, Shin Hye; Kim, Tae-Yong; Kim, Miso; Lee, Kyung-Hun; Lee, Eunshin; Lee, Han-Byoel; Moon, Hyeong-Gon; Han, Wonshik; Noh, Dong-Young; Han, Sae-Won; Kim, Tae-You; Im, Seock-Ah Clinical Breast Cancer, Vol.20 No.2, pp.98-107.e1	DOI
2020-06	Effect of timing of gonadotropin-releasing hormone agonist administration for ovarian protection in patients with breast cancer Shin, Jae Jun; Choi, Young Min; Jun, Jong Kwan; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Wonshik; Im, Seock-Ah Journal of Breast Cancer, Vol.23 No.3, pp.268-278	DOI
2020-06	Antitumor effect of a WEE1 inhibitor and potentiation of olaparib sensitivity by DNA damage response modulation in triple-negative breast cancer Ha, Dong-Hyeon; Min, Ahrum; Kim, Seongyeong; Jang, Hyemin; Kim, So Hyeon; Kim, Hee-Jun; Ryu, Han Suk; Ku, Ja-Lok; Lee, Kyung-Hun; Im, Seock-Ah Scientific Reports, Vol.10 No.1, p. 9930	DOI

1 2 3